Restenosis News and Research

RSS

Restenosis means the reoccurrence of stenosis, a narrowing of a blood vessel, leading to restricted blood flow. Restenosis usually pertains to an artery or other large blood vessel that has become narrowed, received treatment to clear the blockage and subsequently become renarrowed. This is usually restenosis of an artery, or other blood vessel, or possibly a vessel within an organ.

Antiplatelet medication used to treat leg pain may prevent re-blockage of carotid artery stents

Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2020. The conference, Feb. 19-21 in Los Angeles, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

23 Feb 2020

Paclitaxel-coated devices used for widening blocked arteries not linked to increased mortality

Devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths, according to a study of nearly 65,000 patients, published in the European Heart Journal today (Wednesday).

9 Oct 2019

Expert consensus published on use of imaging for precise diagnosis of heart attack

Imaging provides a more precise diagnosis of a heart attack that can be used to individualize treatment. That's the main message of an expert consensus paper published today in European Heart Journal, a journal of the European Society of Cardiology, and presented at EuroPCR in Paris, France.

22 May 2019

New Innovate UK funded project aims to develop biodegradable stents

A £1.1 million project to develop biodegradable stents for patients with severe vascular disease, which affects around one million people in the UK, has started thanks to Innovate UK funding.

9 Apr 2019

Japan-India collaboration results in new treatment approach for male urethral stricture

A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six patients.

25 Nov 2018

$Preclinical studies show differences in healing responses to fractured and intact stent implanted in healthy, disease models$

Preclinical studies show differences in healing responses to fractured and intact stent implanted in healthy, disease models

CBSET, a non-for-profit preclinical research institute dedicated to biomedical research, education and advancement of medical technologies, announced today that its scientists have published data and analyses ("Fracture in drug-eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery") that "illustrate differences in the dynamic healing responses to fractured and intact stent implanted in healthy and disease rabbit models."

30 Oct 2018

Validation of non-invasive stent monitoring techniques

Researchers from the Research Institute Germans Trias i Pujol, the Biomedical Research Networking Center on Cardiovascular Diseases, the University of Barcelona and the the Universitat Politècnica de Catalunya have created a new field probe to detect in a non-invasive and non-ionizing way the presence of metallic stents as well as their potential structural failures through microwave spectrometry.

25 Oct 2018

Drug coated balloons are as good as stent implants for treating small blocked arteries

A removable balloon is as good as a permanent stent implant for opening small blocked arteries, according to late breaking results from the BASKET-SMALL 2 trial presented in a Hot Line Session today at ESC Congress 2018 and simultaneously published in The Lancet.

28 Aug 2018

Erectile dysfunction drug may be used to coat stents in future heart surgeries

Coating stents with an erectile dysfunction drug may be the way forwards in treating stent patients, say researchers.

12 Jul 2017

New study reveals impact of race, gender and socioeconomic status on PCI outcomes

A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at a greater risk of experiencing recurrent cardiac events within the first year after their procedure compared to Caucasian men.

12 May 2017

Expert encourages cardiologists to continue using conventional drug-eluting stents

In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.

6 Apr 2017

Simple fix could eliminate unnecessary coronary stenting procedures

Physician researchers at Thomas Jefferson University suspect that some cases of coronary artery spasm go unrecognized and are incorrectly treated with stents.

20 Mar 2017

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition.

2 Nov 2016

BBK II trial compares two commonly used stenting techniques for coronary bifurcation

Coronary bifurcations - a type of coronary artery narrowing - are best treated with a technique known as culotte stenting, as opposed to T-and-protrusion (TAP) stenting, when there is need for a side-branch stent according to results of the BBK II (Bifurcations Bad Krozingen) trial.

30 Aug 2016

Leader of materials technology development at Lucideon publishes third book on medical polymers

Lucideon, the materials technology company, is pleased to announce that its Head of Medical Materials, Dr Xiang Zhang, has recently published his third book, Science and Principles of Biodegradable and Bioresorbable Medical Polymers.

From Lucideon 12 Jul 2016

UH cardiologists implant first Abbott Absorb stent on patient with coronary artery disease

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent.

11 Jul 2016

UH implants Abbott's Absorb dissolving stent on coronary artery disease patient

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent works exactly as its traditional metallic predecessors in that it opens a blocked coronary artery, with one major exception - it dissolves completely in the body two to three years after implantation.

10 Jul 2016

Loyola among first health systems to offer absorbable stent to heart patients

Loyola Medicine will be among the first health systems in the country to offer heart patients a new stent that is absorbed by the body once it has served its purpose.

7 Jul 2016

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease.

5 Jul 2016

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

A first-in-human trial of an everolimus-eluting bioresorbable vascular scaffold has shown that the device can achieve a high 2-year patency rate and low 2-year target lesion revascularisation rate in patients with peripheral artery disease involving the external iliac artery and superficial femoral artery.

23 Jun 2016